Medicare Payment Demo Would Put Often-Prescribed Cancer Drugs ‘Underwater’
Community oncology practices and hospitals strongly object to CMS’ plan for testing different reimbursement formula Part B drugs, which is expected to particularly impact treatments for cancer, arthritis and eye disease.
You may also be interested in...
President-elect Trump’s selection for HHS secretary, Rep. Tom Price, R-Ga., has been an outspoken critic of the proposed Medicare Part B drug demonstration project.
US HHS Office of Inspector General clears company program to provide travel expenses and lodging to needy patients located far from designated treatment centers.
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.